Our Head of CGT Expression Technologies is heading to CAR-TCR Summit in Boston MA, between 15-17 September 2026 to connect with researchers and industry leaders working across T-cell therapies.
Interested in how SynGenSys can help modulate gene expression for T-cell therapies, or want to explore our T-cell promoter libraries and de novo promoter design capabilities? Come and meet us at the Summit to discuss how we could support your expression strategy.
